pulmonary hypertension
Conditions
Interventions
1:target drug
Sponsors
Fuwai Hospital, CAMS&PUMC
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. The age is 18-85 years old, male and female. 2. Patients with pulmonary hypertension confirmed by right cardiac catheterization should meet the following conditions: 1) MPAP = 25mmHg in right cardiac catheter at rest 2) PVR = 3wood/m2 unit 3) PAWP=15mmHg 3. According to the clinical standard diagnosis process, the patient was diagnosed as pulmonary hypertension, and the specific description is as follows: 1) Pulmonary hypertension 2) Pulmonary hypertension caused by respiratory diseases and/or hypoxia 3) Pulmonary hypertension caused by pulmonary artery obstructive disease 4) Pulmonary hypertension caused by unknown factors 4. Take a new targeted drug for pulmonary hypertension at least within 30 days; 5. Be able to master the use of wearable equipment; 6. The patient signs a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of pulmonary hypertension targeted drug allergy or previous drug-related diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| drug induced disease; | — |
Countries
China
Contacts
Public ContactXinxin Yan
Fuwai Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College
Outcome results
None listed